A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer

202068 citationsJournal Articlegold Open Access

Authors

Xiangkun Wu · First Affiliated Hospital of Guangzhou Medical University

Daojun Lv · Guangzhou Medical University

Chao Cai · Guangzhou Institute of Dermatology

Zhijian Zhao · Guangzhou Institute of Dermatology

Ming Wang · Guangzhou Medical University

Wenzhe Chen · Guangzhou Medical University

Yongda Liu

Abstract

TIPS derived from TP53 mutation status is a potential prognostic signature or therapeutic target but additional prospective studies are necessary to confirm this potential.

Topics & Keywords

Bladder and Urothelial Cancer Treatments Cancer Immunotherapy and Biomarkers Ferroptosis and cancer prognosis

UN Sustainable Development Goals

No poverty

Publication Details

Published in: Frontiers in Immunology

Volume 11, pp. 590618-590618

DOI: 10.3389/fimmu.2020.590618

Field-Weighted Citation Impact: 8.99